Learn how to configure the unblinding of clinical trial Cases for Studies without Study Arms in Vaults with the Isolate Blinded Product Information feature configured.
About the Feature
With the 24R3 release, Vault Safety extends the bulk unblind feature to studies in Vaults configured to isolate blinded product information for clinical trial cases. This allows users to unblind all clinical trial Cases for Studies without Study Arms efficiently. After bulk unblinding, Vault removes blind protection from previously unblinded Cases and populates Study Product information for blinded Cases. Vault also preserves all information by generating separate blinded and unblinded records for all global and localized records. Vault does not modify in-flight Cases as part of bulk unblinding.
After configuring this feature, see Bulk Unblind Isolated Blinded Product Information for more information.
Configuration Requirements
To configure this feature in your Vault, you must enable: